ADRIANA ORTIZ: Open Payments
NPI 1730849985 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 36 payments from 8 companies in 2025. Trend: 2023 $1,104 · 2024 $2,064 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $571 |
| Ardelyx, Inc. | 6 | $138 |
| Gilead Sciences, Inc. | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 3 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
Products named: RINVOQ, SKYRIZI, IBSRELA, Epclusa, LINZESS, REZDIFFRA, VOQUEZNA, TERLIVAZ.
Industry payments across NY — which companies pay providers there.
